Literature DB >> 22037760

A role for SMN exon 7 splicing in the selective vulnerability of motor neurons in spinal muscular atrophy.

Matteo Ruggiu1, Vicki L McGovern, Francesco Lotti, Luciano Saieva, Darrick K Li, Shingo Kariya, Umrao R Monani, Arthur H M Burghes, Livio Pellizzoni.   

Abstract

Spinal muscular atrophy (SMA) is an inherited motor neuron disease caused by homozygous loss of the Survival Motor Neuron 1 (SMN1) gene. In the absence of SMN1, inefficient inclusion of exon 7 in transcripts from the nearly identical SMN2 gene results in ubiquitous SMN decrease but selective motor neuron degeneration. Here we investigated whether cell type-specific differences in the efficiency of exon 7 splicing contribute to the vulnerability of SMA motor neurons. We show that normal motor neurons express markedly lower levels of full-length SMN mRNA from SMN2 than do other cells in the spinal cord. This is due to inefficient exon 7 splicing that is intrinsic to motor neurons under normal conditions. We also find that SMN depletion in mammalian cells decreases exon 7 inclusion through a negative feedback loop affecting the splicing of its own mRNA. This mechanism is active in vivo and further decreases the efficiency of exon 7 inclusion specifically in motor neurons of severe-SMA mice. Consistent with expression of lower levels of full-length SMN, we find that SMN-dependent downstream molecular defects are exacerbated in SMA motor neurons. These findings suggest a mechanism to explain the selective vulnerability of motor neurons to loss of SMN1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037760      PMCID: PMC3255708          DOI: 10.1128/MCB.06077-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

Review 1.  The role of RNP biogenesis in spinal muscular atrophy.

Authors:  Ashwin Chari; Elham Paknia; Utz Fischer
Journal:  Curr Opin Cell Biol       Date:  2009-03-13       Impact factor: 8.382

2.  An assembly chaperone collaborates with the SMN complex to generate spliceosomal SnRNPs.

Authors:  Ashwin Chari; Monika M Golas; Michael Klingenhäger; Nils Neuenkirchen; Bjoern Sander; Clemens Englbrecht; Albert Sickmann; Holger Stark; Utz Fischer
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

3.  Preparation of efficient splicing extracts from whole cells, nuclei, and cytoplasmic fractions.

Authors:  Naoyuki Kataoka; Gideon Dreyfuss
Journal:  Methods Mol Biol       Date:  2008

4.  Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.

Authors:  J Pearn
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

Review 5.  Deciphering the assembly pathway of Sm-class U snRNPs.

Authors:  Nils Neuenkirchen; Ashwin Chari; Utz Fischer
Journal:  FEBS Lett       Date:  2008-03-17       Impact factor: 4.124

6.  Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.

Authors:  Stefania Corti; Monica Nizzardo; Martina Nardini; Chiara Donadoni; Sabrina Salani; Dario Ronchi; Francesca Saladino; Andreina Bordoni; Francesco Fortunato; Roberto Del Bo; Dimitra Papadimitriou; Federica Locatelli; Giorgia Menozzi; Sandra Strazzer; Nereo Bresolin; Giacomo P Comi
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

7.  Regulation of SMN protein stability.

Authors:  Barrington G Burnett; Eric Muñoz; Animesh Tandon; Deborah Y Kwon; Charlotte J Sumner; Kenneth H Fischbeck
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

8.  A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice.

Authors:  Eileen Workman; Luciano Saieva; Tessa L Carrel; Thomas O Crawford; Don Liu; Cathleen Lutz; Christine E Beattie; Livio Pellizzoni; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2009-03-27       Impact factor: 6.150

Review 9.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

10.  Differential 3' splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNP.

Authors:  Mafalda Martins de Araújo; Sophie Bonnal; Michelle L Hastings; Adrian R Krainer; Juan Valcárcel
Journal:  RNA       Date:  2009-02-25       Impact factor: 4.942

View more
  58 in total

1.  Reorganization of Cajal bodies and nucleolar targeting of coilin in motor neurons of type I spinal muscular atrophy.

Authors:  Olga Tapia; Rocío Bengoechea; Ana Palanca; Rosa Arteaga; J Fernando Val-Bernal; Eduardo F Tizzano; María T Berciano; Miguel Lafarga
Journal:  Histochem Cell Biol       Date:  2012-02-01       Impact factor: 4.304

Review 2.  Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Authors:  Sarah Tisdale; Livio Pellizzoni
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

Review 3.  Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophy.

Authors:  Eileen Workman; Stephen J Kolb; Daniel J Battle
Journal:  Brain Res       Date:  2012-02-28       Impact factor: 3.252

4.  A Drosophila model of spinal muscular atrophy uncouples snRNP biogenesis functions of survival motor neuron from locomotion and viability defects.

Authors:  Kavita Praveen; Ying Wen; A Gregory Matera
Journal:  Cell Rep       Date:  2012-06-21       Impact factor: 9.423

Review 5.  SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease.

Authors:  Darrick K Li; Sarah Tisdale; Francesco Lotti; Livio Pellizzoni
Journal:  Semin Cell Dev Biol       Date:  2014-04-24       Impact factor: 7.727

Review 6.  Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Authors:  Jonathan J Cherry; Dione T Kobayashi; Maureen M Lynes; Nikolai N Naryshkin; Francesco Danilo Tiziano; Phillip G Zaworski; Lee L Rubin; Jill Jarecki
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738

7.  SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.

Authors:  Mohini Jangi; Christina Fleet; Patrick Cullen; Shipra V Gupta; Shila Mekhoubad; Eric Chiao; Norm Allaire; C Frank Bennett; Frank Rigo; Adrian R Krainer; Jessica A Hurt; John P Carulli; John F Staropoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

8.  An SMN-dependent U12 splicing event essential for motor circuit function.

Authors:  Francesco Lotti; Wendy L Imlach; Luciano Saieva; Erin S Beck; Le T Hao; Darrick K Li; Wei Jiao; George Z Mentis; Christine E Beattie; Brian D McCabe; Livio Pellizzoni
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

Review 9.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

Review 10.  Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.

Authors:  Ryan S Anderton; Bruno P Meloni; Frank L Mastaglia; Sherif Boulos
Journal:  Mol Neurobiol       Date:  2013-01-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.